Tools

LEADER 03242cam 2200445Ia 4500

001 ocn265657867;

003 OCoLC;

005 20141212022044.0;

008 081027s2009 nyua b 001 0 eng ;

010 a| 2008047209;

020 a| 9780387895192;

020 a| 0387895191;

035 a| (Sirsi) o265657867;

035 a| (OCoLC)265657867;

049 a| NEHH;

245 00 a| Therapeutic targets of the TNF superfamily /c| edited by Iqbal S. Grewal.;

300 a| xvii, 220 pages :b| illustrations (some color) ;c| 26 cm.;

336 a| text2| rdacontent;

337 a| unmediated2| rdamedia;

338 a| volume2| rdacarrier;

490 1 a| Advances in experimental medicine and biology ;v| v. 647;

504 a| Includes bibliographical references and index.;

505 0 a| Overview of TNF superfamily : a chest full of potential therapeutic targets / Iqbal S. Grewal -- Therapeutic interventions targeting CD40L (CD154) and CD40 : the opportunities and challenges / Che-Leung Law and Iqbal S. Grewal -- Targeting TNF for treatment of cancer and autoimmunity / Gautam Sethi ... [et al.] -- Targeting of BAFF and APRIL for autoimmunity and oncology / Maureen C. Ryan and Iqbal S. Grewal -- The role of FASL and FAS in health and disease / Martin Ehrenschwender and Harald Wajant -- OX40 (CD134) and OX40L / Michael J. Gough and Andrew D. Weinberg -- Targeting CD70 for human therapeutic use / Tamar Boursalian ... [et al.] -- 4-1BB as a therapeutic target for human disease / Seung-Woo Lee and Michael Croft -- Rank(L) as a key target for controlling bone loss / Andreas Leibbrandt and Josef M. Penninger -- Targeting the light-HVEM pathway / Carl F. Ware --;

505 0 a| GITR : a modulator of immune response and inflammation / Giuseppe Nocentini and Carlo Riccardi -- Targeting CD30/CD30L in oncology and autoimmune and inflammatory diseases / Ezogelin Oflazoglu, Iqbal S. Grewal, and Hans Peter Gerber -- Tumor necrosis factor receptor superfamily member 21 : TNFR-related death receptor-6, DR6 / Robert Benschop, Tao Wei, and Songqing Na -- TRAIL and other TRAIL receptor agonists as novel cancer therapeutics / Christina Falschlehner ... [et al.] -- Therapeutic potential of VEGI/TL1A in autoimmunity and cancer / Gautam Sethi, Bokyung Sung and Bharat B. Aggarwal.;

650 0 a| Tumor Necrosis Factor-alpha.?| UNAUTHORIZED;

650 0 a| Tumor necrosis factorx| Agonistsx| Therapeutic use.=| ^A237463;

650 12 a| Tumor Necrosis Factorsx| therapeutic use.=| ^A1205349;

650 22 a| Autoimmune Diseasesx| drug therapy.=| ^A1201998;

650 22 a| Inflammationx| drug therapy.=| ^A919691;

650 22 a| Neoplasmsx| drug therapy.=| ^A918295;

650 22 a| Receptors, Tumor Necrosis Factorx| therapeutic use.=| ^A1204726;

700 1 a| Grewal, Iqbal S.=| ^A1209521;

830 0 a| Advances in experimental medicine and biologyv| v. 647.=| ^A103;

994 a| C0b| NEH;

096 a| QW 568 T398 2009;

596 a| 4;

998 a| 1610861;

999 a| QW 568 T398 2009w| NLMc| 1i| 31740082592301d| 2/1/2011f| 2/1/2011g| 1l| HSLBKm| HSLp| $159.00r| Ys| Yt| HBKu| 3/20/2009x| BOOKz| HSTACKSo| .STAFF. 0;

Therapeutic targets of the TNF superfamily / edited by Iqbal S. Grewal.

Other author	Grewal, Iqbal S.
Format	Book
Publication Info	New York, N.Y. : Springer Science+Business Media ; Austin, Tex. : Landes Bioscience, ©2009.
Description	xvii, 220 pages : illustrations (some color) ; 26 cm.
Subjects	Tumor Necrosis Factor-alpha. Tumor necrosis factor--Agonists. --Therapeutic use. Tumor Necrosis Factors--therapeutic use. Autoimmune Diseases--drug therapy. Inflammation--drug therapy. Neoplasms--drug therapy. Receptors, Tumor Necrosis Factor--therapeutic use.

Series	Advances in experimental medicine and biology ; v. 647 Advances in experimental medicine and biology v. 647. ^A103
Contents	Overview of TNF superfamily : a chest full of potential therapeutic targets / Iqbal S. Grewal -- Therapeutic interventions targeting CD40L (CD154) and CD40 : the opportunities and challenges / Che-Leung Law and Iqbal S. Grewal -- Targeting TNF for treatment of cancer and autoimmunity / Gautam Sethi ... [et al.] -- Targeting of BAFF and APRIL for autoimmunity and oncology / Maureen C. Ryan and Iqbal S. Grewal -- The role of FASL and FAS in health and disease / Martin Ehrenschwender and Harald Wajant -- OX40 (CD134) and OX40L / Michael J. Gough and Andrew D. Weinberg -- Targeting CD70 for human therapeutic use / Tamar Boursalian ... [et al.] -- 4-1BB as a therapeutic target for human disease / Seung-Woo Lee and Michael Croft -- Rank(L) as a key target for controlling bone loss / Andreas Leibbrandt and Josef M. Penninger -- Targeting the light-HVEM pathway / Carl F. Ware --
Contents	GITR : a modulator of immune response and inflammation / Giuseppe Nocentini and Carlo Riccardi -- Targeting CD30/CD30L in oncology and autoimmune and inflammatory diseases / Ezogelin Oflazoglu, Iqbal S. Grewal, and Hans Peter Gerber -- Tumor necrosis factor receptor superfamily member 21 : TNFR-related death receptor-6, DR6 / Robert Benschop, Tao Wei, and Songqing Na -- TRAIL and other TRAIL receptor agonists as novel cancer therapeutics / Christina Falschlehner ... [et al.] -- Therapeutic potential of VEGI/TL1A in autoimmunity and cancer / Gautam Sethi, Bokyung Sung and Bharat B. Aggarwal.
Bibliography note	Includes bibliographical references and index.
LCCN	2008047209
ISBN	9780387895192
ISBN	0387895191

Availability

Library	Location	Call Number	Status	Item Actions
Laupus	Books - Stacks	QW 568 T398 2009	✔ Available	Place Hold

Therapeutic targets of the TNF superfamily / edited by Iqbal S. Grewal.

Click here for more information about this title

Availability